Carola Saure1, Carolina Caminiti2, Julieta Weglinski3, Fernanda de Castro Perez4, Soledad Monges5. 1. Department of Nutrition and Diabetes, Hospital JP Garrahan, Argentina. Electronic address: gocarola@fibertel.com.ar. 2. Department of Nutrition and Diabetes, Hospital JP Garrahan, Argentina. Electronic address: carocaminiti@gmail.com. 3. Department of Nutrition and Diabetes, Hospital JP Garrahan, Argentina. Electronic address: julietaweglinski@gmail.com. 4. Head of Day Hospital, Hospital J P Garrahan, Argentina. Electronic address: mariferdc@gmail.com. 5. Department of Neurology, Hospital J P Garrahan, Argentina. Electronic address: mmonges@intramed.net.
Abstract
INTRODUCTION: Duchenne muscular dystrophy (DMD) is a severe muscular disease characterized by progressive loss of functional muscle mass followed by changes in body composition. AIM: To describe body composition, resting energy expenditure (REE), and metabolic disorders in DMD patients followed-up at a tertiary care center. To analyze the association with type of steroid and ambulatory status, and to compare obese DMD patients with patients with multifactorial obesity. POPULATION AND METHODS: A prospective, observational, cross-sectional study was conducted. Anthropometric measurements were taken, evaluating body composition with bioelectrical impedance analysis (BIA), REE with indirect calorimetry, and biochemical parameters in all DMD patients seen between June 2013 and April 2014. RESULTS: 63 boys between 5.4 and 18.7years of age were evaluated. Diagnosis of obesity ranged from 28% measuring body mass indexZ-score (BMIZ-score) to 70% using percentage of fat mass (%FM). Patients who had lost gait had a significantly higher %FM than those in whom gait was preserved (72% vs 46%, p<0.05). Insulin resistance was present in 29% associated with BMI Z-score and waist circumference and 40% had dyslipidemia associated with %FM, both of which were steroid independent. In obese DMD patients REE was lower than predicted and also lower than controls, and persist when dividing the patients into ambulators and non-ambulators. CONCLUSIONS: A high prevalence of obesity was observed. BMI-Z-score underestimates the degree of FM. No correlation was found between steroid type and body composition or metabolic disorders. No differences were found in REE between ambulators and non-ambulators. Obese DMD patients have a lower REE than controls.
INTRODUCTION:Duchenne muscular dystrophy (DMD) is a severe muscular disease characterized by progressive loss of functional muscle mass followed by changes in body composition. AIM: To describe body composition, resting energy expenditure (REE), and metabolic disorders in DMDpatients followed-up at a tertiary care center. To analyze the association with type of steroid and ambulatory status, and to compare obeseDMDpatients with patients with multifactorial obesity. POPULATION AND METHODS: A prospective, observational, cross-sectional study was conducted. Anthropometric measurements were taken, evaluating body composition with bioelectrical impedance analysis (BIA), REE with indirect calorimetry, and biochemical parameters in all DMDpatients seen between June 2013 and April 2014. RESULTS: 63 boys between 5.4 and 18.7years of age were evaluated. Diagnosis of obesity ranged from 28% measuring body mass indexZ-score (BMIZ-score) to 70% using percentage of fat mass (%FM). Patients who had lost gait had a significantly higher %FM than those in whom gait was preserved (72% vs 46%, p<0.05). Insulin resistance was present in 29% associated with BMI Z-score and waist circumference and 40% had dyslipidemia associated with %FM, both of which were steroid independent. In obeseDMDpatients REE was lower than predicted and also lower than controls, and persist when dividing the patients into ambulators and non-ambulators. CONCLUSIONS: A high prevalence of obesity was observed. BMI-Z-score underestimates the degree of FM. No correlation was found between steroid type and body composition or metabolic disorders. No differences were found in REE between ambulators and non-ambulators. ObeseDMDpatients have a lower REE than controls.
Authors: Juan Liu; Dominik Saul; Kai Oliver Böker; Jennifer Ernst; Wolfgang Lehman; Arndt F Schilling Journal: Biomed Res Int Date: 2018-04-16 Impact factor: 3.411
Authors: Karina M Vermeulen; Márcia M G D Lopes; Evellyn C Grilo; Camila X Alves; Richele J A Machado; Lucia L Lais; José Brandão-Neto; Sancha H L Vale Journal: Food Nutr Res Date: 2019-04-10 Impact factor: 3.894
Authors: Ingrid E C Verhaart; Davy van de Vijver; Joke W Boertje-van der Meulen; Kayleigh Putker; Kevin Adamzek; Annemieke Aartsma-Rus; Maaike van Putten Journal: PLoS One Date: 2019-04-24 Impact factor: 3.240
Authors: Sabrina Ravaglia; Rachele de Giuseppe; Annalisa Carlucci; Susan Jehne; Grazia Crescimanno; Lara Ahmad; Matteo Paoletti; Gabriele Clemente; Anna Pichiecchio; Rosella Bazzano; Serena Cirio; Enza Maria Valente; Cesare Danesino; Paola De Filippi; Alice Tartara; Hellas Cena Journal: Front Cell Dev Biol Date: 2022-02-18
Authors: Sandra Murphy; Margit Zweyer; Michael Henry; Paula Meleady; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck Journal: Clin Proteomics Date: 2018-10-29 Impact factor: 3.988